(UPDATE) Daratumumab
Elotuzumab
Teclistamab-cqyv
CAR T-Cell Therapies: Idecabtagene Vicleucel and Ciltacabtagene Autoleucel
Selinexor
The Leukemia and Lymphoma Society
NCCN Patient Resources
International Myeloma Foundation (IMF)
Multiple Myeloma Research Foundation (MMRF)